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Chronic joint instability and progressive OA were induced in rabbit knees by surgical transection of the ACL. Under halothane anesthesia, laser speckle perfusion imaging (LSPI) was used to measure MCL blood flow in unoperated control (n ϭ 12) and 6-wk ACL-transected knees (n ϭ 12). ACh, bradykinin, histamine, substance P (SP), and prostaglandin E2 (PGE2) were applied to the MCL vasculature in topical boluses of 100 l (dose range 10 Ϫ14 to 10 Ϫ8 mol). In normal joints, ACh, bradykinin, histamine, and PGE 2 evoked a dilatory response. Substance P caused a biphasic response that was dilatory from 10 Ϫ14 to 10 Ϫ11 mol and constricting at higher doses. In ACL-deficient knees, ACh, bradykinin, histamine, and SP decreased perfusion, whereas PGE 2 had a biphasic response that decreased perfusion at 10 Ϫ14 to 10 Ϫ11 mol and was dilatory at higher concentrations. Sodium nitroprusside increased perfusion in resting and phenylephrine-precontracted vessels with no significant differences between ACLtransected and control knees. Femoral artery occlusion and release increased perfusion by 74.3 Ϯ 11.1% in control knees but only by 25.8 Ϯ 4.4% in ACL-deficient knees. The altered responsiveness of the MCL vasculature to these inflammatory mediators may indicate endothelial dysfunction in the MCL, which may contribute to the progression and severity of OA and to the adaptation of the joint in an altered mechanical environment. medial collateral ligament; blood flow; laser speckle imaging THE HEALING CAPACITY OF THE medial collateral (MCL) and anterior cruciate ligaments (ACL) correlates with the degree of increased vascularity after injury (7) . In the ACL-deficient model of osteoarthritis (OA), the MCL undergoes a series of adaptive structural and functional changes similar to those seen in a directly injured MCL (6, 8, 41) . Assessing the responsiveness of the MCL vasculature to vasoactive molecules that indicate the functional state of the tissue may prove beneficial in understanding this complex pathology.
Decreased vascular responsiveness to a variety of vasoactive molecules has been shown in the ACL-deficient knee, including calcitonin gene-regulating peptide (Ref. 39) , neuropeptide Y, and phenylephrine (41) . Loss of responsiveness to these molecules may indicate a global loss of vasomotor function in the OA model as part of an adaptation to the altered biomechanical environment of the knee. Assessment of vasomotor function through the use of vasoactive molecules with different modes of action [ACh, bradykinin, histamine, substance P (SP), and prostaglandin E 2 (PGE 2 )] may help to determine the extent of vascular and endothelial dysfunction.
ACh induces vasodilation via two receptors located on endothelial cells (1, 38) The M 2 and M 3 receptors increase cellular calcium concentrations on ligand binding. An increase in intracellular calcium in endothelial cells activates endothelial-derived nitric oxide synthase (eNOS; Refs. 1, 10, 38, 42) . Nitric oxide (NO) ultimately induces hyperpolarization and relaxation of vascular smooth muscle. Loss of responsiveness to ACh has become the gold standard for detecting endothelial dysfunction (11, 27, 37, 42, 52) . Sodium nitroprusside, an exogenous NO donor, can be used to test endothelium-independent relaxation in blood vessels, and it has become an important control in the test of endothelial function (28, 43) .
Bradykinin stimulates vascular responses through the B 2 receptor (42, 51) . The B 2 receptor is a G protein-coupled receptor that is constitutively expressed in the vasculature and is capable of increasing intracellular calcium concentrations in both endothelial cells and vascular smooth muscle cells. Activation of the B 2 receptor in endothelial cells results in the release of two vasoactive compounds: prostaglandin I 2 and NO (42, 51) . Prostaglandin I 2 activates the inositol phosphate receptor to induce vasodilation and inhibit platelet aggregation (42) .
The vasoactive effects of histamine are tissue dependent. Chiba and Tsukada (13) have shown that removal of the vascular endothelium almost completely removes the dilatory effect of histamine, whereas contractile effects remain. Histamine-induced vasodilation appears to be mediated only by the H 1 receptor, whereas both the H 1 and the H 2 receptors mediate the contractile effects (13) . Similarly, substance P-induced vasodilation is endothelium-dependent, mediated through the neurokinin (NK) type 1 receptor. In the absence of an intact functional endothelium, substance P induces vasoconstriction. The NK type 2 and NK type 3 receptors do not appear to have any function in vasoregulation (45) . PGE 2 mediates both vasoconstrictor and vasodilator responses in different tissues. Four receptor subtypes have been cloned and are designated E1, E2, E3, and E4, all of which are G protein-coupled receptors. The E1 and E3 receptors induce vasoconstriction, and conversely, the E2 and E4 receptors induce vasodilation (14) . The E1 receptor functions through a G q pathway to cause an increase in intracellular calcium and is highly active in the vas deferens and iliac smooth muscle (15) . The E3 receptor is coupled to a G i pathway and causes an inhibition of cAMP accumulation (50) . The E2 and E4 receptors are coupled to Gs pathways and cause an increase in intracellular cAMP (15, 32, 33) . These two receptors are differentiated only by their affinity for different selective agonists, butaprost and (PGE 1 )-OH respectively (15, 32) .
Response to shear stress has become a noninvasive diagnostic tool to assess endothelial function in patients (54) . Following a period of occlusion, postocclusion arterial flow is increased, and stretch-activated receptors induce activation of eNOS to produce NO and induce vascular smooth muscle dilation (47, 56) . Diminished response to shear stress is also indicative of endothelial dysfunction. (27, 54) .
Under chronic inflammatory conditions, the vasculature may also become inflamed (20, 49 ). An inflamed vasculature may become involved in proinflammatory processes and may contribute to the chronicity and severity of the pathology. Examination of vascular functioning can indicate the condition of the vasculature in this injury OA model, and it may aid in understanding the progression of OA and the injury response of the MCL in this model. The questions addressed by these studies are: what are the responses of the MCL vasculature and the endothelium in a chronic degenerative OA model with some aspects of inflammation, and if these responses are abnormal, do they implicate any other pathological conditions that may be involved?
METHODS
Twenty-four skeletally mature 1-yr-old New Zealand White rabbits (4.5-6.5 kg) were used in two cohort groups: unoperated control (n ϭ 12) and 6-wk ACL transected (n ϭ 12). Both cohorts were further divided into groups of six for blood flow assessment. Previous studies have shown no significant effect of sham operation on tissue blood flow at 6 wk (5-7); therefore, a sham-operated group was omitted, and normal controls were used. Rabbits were kept on a 12:12-h light-dark cycle, and they were fed standard laboratory chow and tap water ad libitum. All animals were treated and maintained according to the Canadian Council on Animal Care Guidelines under a protocol approved by the Faculty of Medicine Animal Care Committee.
ACL transection. Rabbits were given 0.18 ml of acepromazine maleate (Atravet) intravenously and anesthetized with halothane (2-5%, 1.0 l/min O 2). An anterior tibial draw test was performed before surgery to ensure that there was no preexisting ACL injury condition. An anterolateral surgical approach was used. The patellar fat pad was retracted, the ACL was isolated using a hooked probe, and the ligament was cut using a no. 11 surgical blade. A second anterior tibial draw was performed to ensure that the transection was complete. Following surgery, rabbits were treated with standard antibiotics and analgesics and allowed to resume normal cage activity for 6 wk.
Blood flow imaging. Under halothane anesthesia (1-2%, 1 l O 2/ min), the MCL was surgically exposed. Overlying fascia was carefully dissected away without damaging the network of blood vessels supplying the MCL. Blood flow was measured using laser speckle perfusion imaging (LSPI). Full details of this instrument can be found in previous publications (5, 17, 18) . Briefly, a 635-nm laser source is connected by a fiber-optic cable to the LSPI instrument head, which also contains a black and white charge-coupled device camera with a close-focus imaging zoom lens. The instrument head was placed 23 cm directly above the MCL for a uniform and simultaneous illumination of the entire region of interest, and the lens focus was adjusted until the region of interest filled the camera field of view. Exposure time was set at 15 ms. LSPI camera output was fed directly to a live monitor for continuous video of the laser-illuminated tissue and to a computer for simultaneous capture and digitization of speckle images. High-resolution digital images were processed using custom LSPI algorithms to produce quantitative color-coded perfusion maps of tissue blood flow (Fig. 1 ). Images were analyzed to determine average perfusion values within a user-specified region defined by the anatomical borders of the MCL. Figure 1 shows examples of color-coded perfusion images of the MCL and the defined analysis regions used to produce the perfusion values. Results are presented as mean perfusion units (PU) Ϯ SE. Drug application. After surgical exposure of the MCL, 100-l aliquots of ACh, bradykinin, histamine, PGE 2, and SP were topically applied in a random sequential order to the MCL vasculature. After each mediator application, the joint was continuously washed with physiological saline (37°C, 0.9% NaCl), and the tissue allowed to recover until normal blood flow resumed. Doses of histamine, prostaglandin E 2, and SP ranged from 10 Ϫ14 mol to 10 Ϫ8 mol. Perfusion images were captured every 10 s for 9 min after each drug application. The NO donor sodium nitroprusside was administered at 10 Ϫ3 mol to assess smooth muscle reactivity in both resting vessels and in phenylephrine-precontracted vessels in vivo.
Reactive hyperemia assessment. Reperfusion was assessed through femoral artery occlusion. Briefly, basal perfusion was measured using LSPI. The femoral artery was then isolated by blunt dissection and occluded with an artery clamp for 4 min. The clamp was then removed, and blood flow was measured for 6 min postocclusion. Perfusion changes were expressed as percent change from initial blood flow.
Statistical analysis. Mean perfusion values for the MCL in control and ACL-deficient knees were compared for each drug concentration using Student's t test (n ϭ 6 per group; P Ͻ 0.05).
RESULTS
Six weeks following ACL transection, gross morphological changes were observed. Synovial hyperplasia, capsular thickening, MCL scarring, and bucket handle medial meniscal tears were found in all ACL-deficient knees. Cartilage fibrillation and osteophyte formation were not present. Knee joint diameter of ACL-deficient knees was measured with calipers and found to be significantly increased compared with control knees (29.4 Ϯ 0.3 vs. 22.1 Ϯ 0.2 mm; P Ͻ 0.001).
The mean perfusion of control MCLs was 7.41 Ϯ 1.22 PU. In accordance with our previously published results (41), perfusion of the MCL was significantly increased in ACLdeficient knees to a mean of 18.32 Ϯ 1.76 PU (P Յ 0.006). Representative LSPI of the MCL in control and ACL-deficient knees are shown in Fig. 1, a and b . Topical application of saline did not alter blood flow in either control knees (Fig. 1a) or in ACL-deficient knees (Fig. 1b) . The resolution of the LSPI was sufficient to detect drug-induced vasoconstriction and vasodilation of the small vessels supplying the MCL (Fig. 1, c  and d) .
Drug responses. ACh increased perfusion in a dose-dependent manner in the exposed MCL vasculature. Maximal response to ACh in control knees was observed at 10 Ϫ8 mol where perfusion was increased by 43.1 Ϯ 7.3%. The AChinduced dilatory response was not observed in ACL-deficient knees. ACh reduced perfusion in ACL-deficient knees by Ϫ3.9 Ϯ 0.2% at 10 Ϫ8 mol (Fig. 2) . Similarly, bradykinin increased perfusion to the MCL vasculature in control knees in a dose-dependent manner. Maximal dilation was observed at 10 Ϫ9 mol. At this concentration, bradykinin increased perfusion by 32.3 Ϯ 3.3%. The dilatory response to bradykinin was not observed in ACL-deficient knees, and at 10 Ϫ9 mol, bradykinin decreased perfusion by Ϫ9.8 Ϯ 3.3% (Fig. 3) .
Exposure of the MCL tissue to histamine led to the dosedependent induction of vasodilation in control knees with a maximal response obtained at 10 Ϫ9 mol, which increased perfusion by 51.3 Ϯ 5.6% (Fig. 4) . The histamine dilatory response was altered in the ACL-deficient knee, where 10 Ϫ9 mol of histamine decreased perfusion by Ϫ7.8 Ϯ 4.4%.
In control knees, exposure to exogenous SP led to dosedependent increases in perfusion at concentrations from 10 Ϫ14 to 10
Ϫ11 mol and to decreases in perfusion at higher concentrations (Fig. 5) . Maximal dilation was observed at 10 Ϫ12 mol with a mean increase in perfusion of 44.7 Ϯ 7.9% (Fig. 1) . The maximal constrictor response was observed at 10 Ϫ8 mol, significantly decreasing perfusion by Ϫ52.1 Ϯ 11.1%. Following ACL transection, the dilatory phase of the SP response curve was effectively eliminated (Fig. 5) . We did not measure systemic effects associated with the application of SP to the joint Fig. 2 . Effects on perfusion of the medial collateral ligament with topical administration of acetylcholine. Boluses of 0.100 ml of histamine were administered to the exposed medial rabbit knee joint. Values are means Ϯ SE given as %change. *Significant difference between control and ACLdeficient (ACL-X) knees for each dose, P Ͻ 0.05 (Student's t-test).
vasculature; however, blood flow did return to baseline levels between doses, indicating that responses to SP were probably not affected by systemic blood pressure changes.
To test the dilatory responsiveness of vascular smooth muscle, sodium nitroprusside was administered to both the resting vasculature and phenylephrine-precontracted vessels. Nitroprusside increased perfusion in the resting vasculature, but it was more effective in phenylephrine-precontracted vessels in both control and ACL-deficient knees with no significant differences between the two groups. PGE 2 increased perfusion in control knees in a biphasic manner (Fig. 6 ). This response was maximally observed at 10 Ϫ12 and 10 Ϫ8 mol, increasing perfusion by 44.4 Ϯ 9.3 and 42.6 Ϯ 9.1%, respectively. ACL deficiency led to alterations in the dose-response curve compared with that observed in control knees. At concentrations ranging from 10 Ϫ14 to 10 Ϫ11 mol in the ACL-deficient knee, PGE 2 induced a significant decrease in perfusion. Higher concentrations of PGE 2 were still able to induce an increase in perfusion, although this response was still significantly lower than that observed in the control knee. Fig. 3 . Effects on perfusion of the medial collateral ligament with topical administration of bradykinin. Boluses of 0.100 ml of substance P were administered to the exposed medial rabbit knee joint. Values are means Ϯ SE given as %change. *Significant difference between control and ACL-deficient knees for each dose, P Ͻ 0.05, (Students t-test) . Fig. 4 . Effects on perfusion with topical administration of histamine. Boluses of 0.100 ml of prostaglandin E2 were administered to the exposed medial rabbit knee joint. Values are means Ϯ SE given as %change. *Significant difference between control and ACL-deficient knees for each dose, P Ͻ 0.05 (Student's t-test).
Reactive hyperemia assessment. Reactive hyperemia was assessed by femoral artery occlusion and reperfusion in both ACL-deficient and control knees. Femoral artery occlusion resulted in a Ϫ73.6 ϩ 7.3% decrease in perfusion in control knees, and a Ϫ73.0 ϩ 5.8% decrease in ACL-deficient knees (P ϭ 0.95), Release of the femoral artery clamp was followed by reperfusion hyperemia of 74.3 ϩ 11.1% in control knees but of only 25.8 ϩ 4.4% in ACL-deficient knees (Fig. 7) .
DISCUSSION
This study examined the effects of vasoactive mediators in the ACL-deficient model of OA, using high-resolution LSPI to detect rapid changes in blood flow (17, 18) . Following 6 wk of ACL deficiency, the responsiveness of the MCL vasculature was assessed, baseline blood flow in the MCL showed significant 2.5-fold increases, and vasodilatory responses to ACh, Fig. 5 . Effects on perfusion with topical administration of substance P. Boluses of 0.100 ml of prostaglandin E2 were administered to the exposed medial rabbit knee joint. Values are means Ϯ SE given as %change. *Significant difference between control and ACL-deficient knees for each dose, P Ͻ 0.05 (Student's t-test). Fig. 6 . Effects on perfusion with topical administration of prostaglandin E2 (PGE2). Boluses of 0.100 ml of PGE2 were administered to the exposed medial rabbit knee joint. Values are means Ϯ SE given as %change. *Significant difference between control and ACL-deficient knees for each dose, P Ͻ 0.05 (Student's t-test).
bradykinin, SP, histamine, and low doses of PGE 2 were abolished. The response to shear stress was also abrogated in the ACL-deficient knee. Although no specific means of assessing receptor function or modes of action were employed and remain speculative, the physiological responses examined highlight the pathological condition of the vasculature in the ACL-deficient knee, a tissue that has not been extensively studied in OA.
Ligament rupture is a complex injury with multiple phases of healing. Ligament healing generally follows an orderly process of hemorrhage, inflammation, proliferation, and remodeling (19, 55) . Unfortunately, partial ACL injuries show limited healing, whereas complete rupture effectively exhibits no healing response (24) . The resultant chronic joint instability induces structural and physiological changes in intact supporting joint structures such as the MCL, which exhibits changes in mechanical properties and blood flow similar to those seen during scar formation after a direct injury (6, 9, 41) .
Chronic joint instability often culminates in OA, with ACL deficiency in rabbits following a definable time line. At the 6-wk time point, we observed synovial hyperplasia, capsular thickening, MCL scarring, bucket handle medial meniscal tears, and increased knee joint diameter. There was no cartilage fibrillation or osteophyte formation. Similar results have been reported for ACL-deficient rabbit knees by other groups (2, 25, 31, 44, 57) , where joint degeneration and inflammation occurred during the first 8 wk, and both degenerative and regenerative processes occur after 8 wk (44). Molecular alterations have been observed in the ACL-transected knee 6 wk postsurgery (26) and indicate that early-stage OA is present 6 wk after ACL transection.
Tissues in the osteoarthritic joint (synovium, chondrocytes, and adipose tissue) can secrete inflammatory mediators and angiogenic factors, which in turn may induce a chronic inflammatory state (21, 36, 48) . Prominent inflammatory mediators and angiogenic factors are known to induce widespread changes in collagen synthesis, proteoglycan synthesis, and matrix-degrading enzyme production, as well as altering the oxidative state of the affected tissues (reviewed in Refs. 36, 46) . These same inflammatory mediators have been implicated in the altered functional state of the vasculature in atherosclerosis, possibly by eliminating many of the normal homeostatic mechanisms of vessel contractility (35) . Further correlations between inflammatory mediators in both atherosclerosis and rheumatoid arthritis (RA) have indicated that endothelial dysfunction may contribute to RA pathology and that improving endothelial function may prove useful in treating RA (29) . However, little information on endothelial functioning in OA exists.
Traditional evaluation of endothelial function involves use of physical stimuli, such as shear stress; intraluminal use of various vasodilators, such as ACh; and vascular measurement (27) . Endothelial dysfunction results from a decrease in the bioavailability of NO due to both decreased formation and enhanced degradation (27) . Excessive generation of reactive oxygen species, as has been found to occur in many forms of arthritis, may contribute to decreased NO-generating capacity. Because stimulation of vascular smooth muscle by NO results in smooth muscle relaxation, decreased bioavailability and production capacity of NO would impair normal vascular smooth muscle relaxation (27) . In the present study, we chose to use a variety of dilatory stimuli that function through diverse mechanisms of action to establish a broad evaluation of both endothelial function and vascular reactivity. Topical administration of these vasodilators was used to minimize systemic effects on vascular tone and cardiac output. Because topical administration of these agents to an exposed vascular bed elicited a traditional dilatory response that was reproducible in the control vasculature, topical administration was considered an acceptable means of drug delivery. ACh, bradykinin, and histamine induce endothelium-dependent relaxation of vascular smooth muscle through activation of eNOS and NO. ACh is known to induce dilation in vascular smooth muscle via the M 2 and M 3 muscarinic receptors located on endothelial cells, and it has become a diagnostic tool for determining endothelial function (10, 37, 38, 42) . Bradykinin, via the B 2 receptor, increases intracellular calcium in both vascular smooth muscle cells and endothelial cells (3, 4, 22, 23) . Histamine also elicits endothelium-dependent relaxations of conduit elastic and muscular peripheral blood vessels such as the aorta, common carotid, femoral artery, and superior mesenteric arteries through activation of histamine H 1 receptors (12, 13, 30) . In a study of the canine lingual artery, removal of the endothelium drastically reduced the dilatory effects of histamine (13) . ACL deficiency led to an abrogation of normal responses to ACh, bradykinin, and histamine, likely indicating the presence of a dysfunctional endothelium in this model of OA.
Previous reports illustrate the necessity of an intact endothelium for SP-dependent vascular relaxation (45) . Use of the NO synthase inhibitor N G -nitro-L-arginine in the rabbit isolated jugular vein showed that SP-induced relaxation is mediated by the production of NO and that removal of the endothelium eliminates this dilatory response. These authors have also reported that at higher concentrations (Ն100 nM), SP elicits a contractile response (45) . The present results show that similar responses to SP occur in the normal vasculature supplying the MCL, although the contractile effect occurred at a slightly higher concentration. In rabbit coronary arteries, SP has been shown to induce endothelium-dependent relaxation through the production of NO (45) . In these same tissues, SP has been shown to induce endothelium-dependent contraction through the production of thromboxane A 2 (TxA 2 ), which may be inhibited by addition of the cyclooxygenase inhibitor aspirin, the TxA 2 antagonist ONO-3708, and the TxA 2 synthetase inhibitor OKY-046. Therefore, the vasoactive effects of SP are likely dependent on the production of several other mediators, and the loss of the dilatory phase of the SP response in ACL-deficient knees may indicate a decreased capacity of the vasculature to produce or respond to NO. The decreased contractile response observed in the rabbit ACL-deficient pathology may result from alterations in SP endothelial signaling cascades, decreased capacity to produce TXA 2 , or some other mechanism(s). Because SP effects are both tissue and species specific, alterations observed in the rabbit ACL-deficient model may not be applicable to human OA, and this warrants further investigation (34) . PGE 2 differs from the other mediators studied in that this molecule acts directly on vascular smooth muscle. The EP2 and EP4 receptors are responsible for mediating the effects of PGE 2 on vascular smooth muscle and are solely responsible for the vasodilatory effects of PGE 2 (15, 32) . Activation of these receptors increases cytosolic levels of cAMP. In the present study, PGE 2 elicited a biphasic response in the normal cohort (Fig. 6) . A biphasic response was observed in the ACLdeficient cohort, with PGE 2 causing a decrease in perfusion at lower concentrations and an increase in perfusion at higher concentrations, although this response was diminished compared with controls. These results likely indicate the presence of two receptors for PGE 2, each with different affinities for the endogenous ligand; the higher affinity receptor is probably altered or absent in the ACL-deficient knee. Because the EP4 receptor has a higher affinity for PGE 2 than the EP2 receptor (16) , the EP4 receptor is most likely altered in the ACLdeficient cohort. The lack of a vasodilatory response at low PGE 2 concentrations in the ACL-deficient cohort may reflect a downregulation or reduced sensitivity of this receptor.
Flow-mediated dilation has become a valuable tool to detect endothelial dysfunction because of the noninvasive nature of this diagnostic method (27, 52, 54) . Stretch-activated receptors induce NO production in endothelial cells via eNOS and result in smooth muscle relaxation (47) . Femoral artery occlusion resulted in similar decreases in perfusion in both control and ACL-deficient knees, indicating that the vasculature in the ACL-deficient knee has similar capacity for perfusion changes. However, reperfusion following femoral artery occlusion only resulted in a 25% increase in perfusion in ACL-deficient knees compared with an 84% increase in perfusion detected in control knees. This diminished dilatory response in the vasculature indicates profound endothelial dysfunction in this model of OA. Dysfunctional endothelial cells produce proinflammatory mediators and matrix-degrading proteins, increase collagen synthesis, and increase inflammatory cell migration, and they may play a role in joint degeneration in this OA model (11, 40, 49, 53) .
Rupture of the ACL and induction of OA initiates widespread effects that alter the normal homeostatic mechanisms of other supporting structures in the knee, including the MCL (6). Vascular inflammation and endothelial dysfunction are pathologies that not only affect the vasculature but also are responsible for infiltration of leukocytes into the surrounding structures, and they may be involved in initiating inflammatory responses from resident cells in various tissues (reviewed in Ref. 40) . In combination with the altered mechanical environment in the ACL-deficient knee, endothelial dysfunction and vascular inflammation may provide a link between inflammation observed in the joint space and adaptive changes occurring in supporting structures. Amelioration of endothelial and vascular dysfunction not only may provide new insights into OA progression but also may present new methods to initiate joint repair by reducing joint inflammation and associated adaptive changes that may contribute to progression of the disease.
In conclusion, ACL deficiency markedly decreases the responsiveness of the MCL vasculature. The dilatory response to ACh, bradykinin, histamine, and SP and one phase of the PGE 2 dilatory response were abolished. Response to shear stress was also attenuated in the ACL-deficient rabbit knee. Instead, abnormal constrictive responses were observed with lower concentrations of PGE 2 and with administration of ACh, bradykinin, histamine, and SP. Loss of these responses indicates decreased vascular reactivity and endothelial dysfunction in ACL-deficient knees. Further understanding of adaptive mechanisms and vascular changes in degradative OA may provide new therapeutic avenues for slowing progression of the disease and initiating repair processes.
